This study revealed the tumor-promoting effect of p62 in PTC by AKT/AMPK/mTOR pathway, contributing to the basic research on the occurrence and development of PTC, and further suggesting that p62 or p62 related molecule may be a diagnostic and therapeutic target for PTC. The gene discussed is MTOR; the disease is neoplasm.